Power Law company profile

Kuros Biosciences

Biotech & Life Sciences · Zurich, Switzerland · Founded 2000 · IPO 2016 Unicorn

Biologic implants to promote bone healing in spinal and orthopaedic surgery

Valuation

$714M

Market cap · May/2026

Revenue

$134M

Latest reported FY

EBITDA

$15M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

14 investors on Kuros Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Venture Incubator

VI Partners

CDC Innovation

CDC Enterprises

Series B+ 10 investors entered at this stage

Vinci Capital

EQT Life Sciences

University of Zürich

ETH Zurich

Reference Capital

Innovation Capital

Swiss Helvetia Fund

DEFI Gestion

NeoMed

Omega Funds

Global footprint

Where Kuros Biosciences has talent and traffic

Workforce by country

6 countries with
team presence

🇺🇸 United States49.5%

🇳🇱 Netherlands39.5%

🇨🇭 Switzerland7.5%

🇬🇧 United Kingdom1.8%

🇦🇺 Australia0.9%

Top 5 of 6 shown

Patent intelligence

$38M patent portfolio · 15 active families

Estimated portfolio value

$38M

5.4% of market cap · 184.7× smaller than top peer Janssen Vaccines ($7.1B)

15 active patent families

Where Kuros Biosciences innovates Biomedical engineeringVirus-like particleTGE VACCINEMolecular biologyAntibody response

Where Kuros Biosciences concentrates vs peers

Each axis is a top-10 topic across Kuros Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Kuros Biosciences

An AI-synthesized read of the highest-engagement posts about Kuros Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kuros Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles